Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer
DOI: 10.2122/gbc.2002.0008


Circulating Cancer Cells Limit Surgical Potential Urgently Suggesting Research Efforts For Systemic Adjuvant Effective Treatment In Gastric Cancer


Improvements in long-term survival of gastric cancer currently reported particularly from specialized centers are attributable primarily to early detection. By stark contrast survival of advanced gastric carcinoma is even now poor. Recurrence at local or distant sites is often accounting for over 80% among cases with both serosal- and nodal-positive cancers, despite complete tumor resection due to an appropriate, standardized extended surgery. Early gastric cancer recurrence occurs in approximately 70% of all recurrent events. We know now that circulating cancer cells are likely responsible for secondary tumor formation but large recent studies failed to show their prognostic significance. Here, we discuss possible explanations for this high rate of early recurrence.

Comments and questions? Please contact us.
The Gastric Breast Cancer Network Center is owned, published, and copyrighted 2002. All rights reserved.

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 22 May 2003